Mr. Speaker, I would be happy to address this issue. As a result of the 2004 health accord, there was and continues to be work done by the provinces and territories, along with the federal government, on what is called a national pharmaceutical strategy.
Part of conversation is the topic mentioned by the hon. member. There are literally eight or nine other topics of conversation. I look forward to continuing that conversation with my colleagues at the next federal-provincial-territorial meeting.